While the company said that simply giving a third shot of its original vaccine could offer more potent protection against the variant, it wants to begin...
The new shot is expected to play a key role in the fight against coronavirus abroad. Novavax Releases Clinical Trial Findings The American biotech firm Novavax...
FDA officials told reporters Monday that the agency will approve Pfizer’s coronavirus vaccine for children 12 to 15 years old by next week. Last month, Pfizer...
Less than 1 in 4 currently unvaccinated Americans are willing to take Johnson & Johnson’s single-shot COVID-19 vaccine, according to a Washington Post-ABC News poll. The...
As of Monday, every adult in the U.S. who would like to receive a COVID-19 vaccine can get one. According to the CDC, more than 131...
The CDC and the FDA have issued a joint recommendation to pause distribution of Johnson & Johnson’s COVID-19 vaccine amid reports that six women experienced “extremely...
The FDA and CDC approved Johnson & Johnson’s COVID-19 vaccine over the weekend, allowing the company to begin shipping doses Monday for use later this week....
Johnson & Johnson announced Friday that its COVID-19 vaccine was 66% effective overall at preventing moderate to severe cases and 85% effective at preventing severe disease....
Germany’s vaccine committee said AstraZeneca’s COVID-19 vaccine should only be given to people under 65, citing “currently insufficient data” about its efficacy in that age group....
The U.S. Food and Drug Administration has confirmed that vials of the Pfizer COVID-19 vaccine, which began rolling out for emergency use on Monday, were shipped...
